2020. Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s44. DOI:https://doi.org/10.25251/skin.4.supp.44.